Tampa, FL– Dr. William S. Dalton, Moffitt Cancer Center CEO and center director, has been appointed vice president/president-elect of the Association of American Cancer Institutes. Dalton will assume the AACI presidency in 2011.
“It is an honor to be chosen to serve as president-elect of such a prestigious organization,” Dalton said. “I’m looking forward to providing advice and counsel as well as representing the interests of AACI’s member institutions”
The AACI and the Cancer Center Administrators Forum (CCAF) held their 2009 Annual Meeting this week in Washington, D.C. Dalton attended a board meeting in his new role. The meeting brings leaders of AACI cancer centers — center directors and executive-level administrators — together with leaders of national cancer research and advocacy organizations, industry, and government health agencies to share best practices and devise solutions to common challenges.
Dalton was the founding director of the Bone Marrow Transplant Program at the University of Arizona. Dalton was first hired by Moffitt in 1997 as the associate center director for Clinical Investigations and was appointed deputy director in 1999. He was the professor and founding chairman of the Department of Interdisciplinary Oncology, now the Department of Oncologic Sciences, at the University of South Florida from 1999 to 2001. He served as dean of the College of Medicine at the University of Arizona in Tucson from 2001 to 2002. Dalton returned to Moffitt in August 2002 in his current leadership role.
AACI comprises 95 of the leading cancer research centers in the United States. AACI’s membership roster includes National Cancer Institute-designated centers and academic-based cancer research programs that receive NCI support.
The association is dedicated to promoting the nation’s leading research institutions’ efforts to eradicate cancer through a comprehensive and multidisciplinary program of cancer research, treatment, patient care, prevention, education and community outreach.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.